Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Shohet

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the National Cancer Institute|November 12, 2009
Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axisEugene Kim, Jason Shohet
BMJ (Clinical Research Ed.)|May 5, 2017
NeuroblastomaJason Shohet, Jennifer Foster
Life (Basel, Switzerland)|October 26, 2024
Investigation of Cell Mechanics and Migration on DDR2-Expressing Neuroblastoma Cell LineTheadora Vessella, Esteban J Rozen, Jason Shohet, et al.
FEBS Open Bio|March 27, 2024
DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanismsTheadora Vessella, Steven Xiang, Cong Xiao, et al.
Plos One|November 19, 2016
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk NeuroblastomaKetan B Ghaghada, Zbigniew A Starosolski, Anna Lakoma, et al.
Oncotarget|September 17, 2017
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastomaAlan Van Goethem, Nurten Yigit, Myrthala Moreno-Smith, et al.
Scientific Reports|December 1, 2016
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samplesAlan Van Goethem, Nurten Yigit, Celine Everaert, et al.
Scientific Reports|March 13, 2015
Genome wide expression profiling of p53 regulated miRNAs in neuroblastomaAli Rihani, Alan Van Goethem, Maté Ongenaert, et al.
NAR Cancer|January 23, 2023
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivationAlan Van Goethem, Jill Deleu, Nurten Yigit, et al.
Nature Communications|December 11, 2021
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastomaAlexandra D'Oto, Jie Fang, Hongjian Jin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the National Cancer Institute|November 12, 2009
Targeted molecular therapy for neuroblastoma: the ARF/MDM2/p53 axisEugene Kim, Jason Shohet
BMJ (Clinical Research Ed.)|May 5, 2017
NeuroblastomaJason Shohet, Jennifer Foster
Life (Basel, Switzerland)|October 26, 2024
Investigation of Cell Mechanics and Migration on DDR2-Expressing Neuroblastoma Cell LineTheadora Vessella, Esteban J Rozen, Jason Shohet, et al.
FEBS Open Bio|March 27, 2024
DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanismsTheadora Vessella, Steven Xiang, Cong Xiao, et al.
Plos One|November 19, 2016
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk NeuroblastomaKetan B Ghaghada, Zbigniew A Starosolski, Anna Lakoma, et al.
Oncotarget|September 17, 2017
Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastomaAlan Van Goethem, Nurten Yigit, Myrthala Moreno-Smith, et al.
Scientific Reports|December 1, 2016
Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samplesAlan Van Goethem, Nurten Yigit, Celine Everaert, et al.
Scientific Reports|March 13, 2015
Genome wide expression profiling of p53 regulated miRNAs in neuroblastomaAli Rihani, Alan Van Goethem, Maté Ongenaert, et al.
NAR Cancer|January 23, 2023
Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivationAlan Van Goethem, Jill Deleu, Nurten Yigit, et al.
Nature Communications|December 11, 2021
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastomaAlexandra D'Oto, Jie Fang, Hongjian Jin, et al.
Pageof 2